Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
featured
Published in Neurology

Journal Scan / Research · August 27, 2024

Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

Journal of the American Heart Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
J Am Heart Assoc 2024 Aug 20;13(16)e034641, Y Xu, SH Ballew, AR Chang, LA Inker, ME Grams, JI Shin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading